Fund Holdings — BOONE CAPITAL MANAGEMENT LLC

Total Portfolio Value
$304.97M
Total Bought
$132.44M
Total Sold
$83.54M
Net Transaction
+$48.90M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
IONIS PHARMACEUTICALS INC(IONS)0417,833+417,833027,3358.96%+27,335
BRIDGEBIO PHARMA INC(BBIO)0460,282+460,282023,9077.84%+23,907
RAPT THERAPEUTICS INC0782,461+782,461020,1806.62%+20,180
COGENT BIOSCIENCES INC(COGT)0945,042+945,042013,5714.45%+13,571
THE CIGNA GROUP(CI)35,60082,972+47,37211,76923,9177.84%+12,148
KODIAK SCIENCES INC(KOD)0715,877+715,877011,7193.84%+11,719
LIVANOVA PLC(LIVN)0167,932+167,93208,7962.88%+8,796
UNIQURE NV(QURE)0147,317+147,31708,5992.82%+8,599
MIRUM PHARMACEUTICALS INC(MIRM)641,448535,732-105,71632,64339,27512.88%+6,631
CLEARPOINT NEURO INC(CLPT)0283,912+283,91206,1862.03%+6,186
MEDTRONIC PLC(MDT)428,789428,789037,37840,83813.39%+3,460
ICON PLC(ICLR)95,83295,832013,93916,7715.50%+2,832
UNITEDHEALTH GROUP INC(UNH)58,11258,112018,12920,0666.58%+1,937
NEUROCRINE BIOSCIENCES INC(NBIX)180,338166,414-13,92422,66723,3617.66%+695
ABEONA THERAPEUTICS INC(ABEO)1,254,658502,854-751,8047,1262,6550.87%-4,471
BIOMARIN PHARMACEUTICAL INC(BMRN)447,449328,546-118,90324,59617,7945.83%-6,802
PENNANT GROUP INC649,0220-649,02219,3730—-19,373
UNUM GROUP(UNM)281,7900-281,79022,7570—-22,757
AVANTOR INC(AVTR)1,694,4820-1,694,48222,8080—-22,808
Page 1 of 1
BOONE CAPITAL MANAGEMENT LLC — 13F Holdings — Q3 2025 | TickerTrail